SE457055B - Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser - Google Patents

Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Info

Publication number
SE457055B
SE457055B SE8603481A SE8603481A SE457055B SE 457055 B SE457055 B SE 457055B SE 8603481 A SE8603481 A SE 8603481A SE 8603481 A SE8603481 A SE 8603481A SE 457055 B SE457055 B SE 457055B
Authority
SE
Sweden
Prior art keywords
vasopressin
mucosa
tglvp
radiation protection
gel
Prior art date
Application number
SE8603481A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603481L (sv
SE8603481D0 (sv
Inventor
K F Aronsen
G Nylander
S Borgstroem
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8603481A priority Critical patent/SE457055B/sv
Publication of SE8603481D0 publication Critical patent/SE8603481D0/xx
Priority to FI890715A priority patent/FI890715A7/fi
Priority to EP87850244A priority patent/EP0265400B1/fr
Priority to PCT/SE1987/000359 priority patent/WO1988001163A1/fr
Priority to JP62504940A priority patent/JPH02500668A/ja
Priority to DE8787850244T priority patent/DE3770753D1/de
Priority to AT87850244T priority patent/ATE64308T1/de
Priority to AU78528/87A priority patent/AU609417B2/en
Priority to IL83566A priority patent/IL83566A/xx
Publication of SE8603481L publication Critical patent/SE8603481L/
Priority to NO881580A priority patent/NO881580L/no
Priority to DK206688A priority patent/DK206688A/da
Publication of SE457055B publication Critical patent/SE457055B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Colloid Chemistry (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Details Of Aerials (AREA)
  • Support Of Aerials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Cosmetics (AREA)
SE8603481A 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser SE457055B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
AU78528/87A AU609417B2 (en) 1986-08-18 1987-08-14 Topical radioprotective gel for mucosa
JP62504940A JPH02500668A (ja) 1986-08-18 1987-08-14 粘膜用局部的放射線防護ゲル
EP87850244A EP0265400B1 (fr) 1986-08-18 1987-08-14 Gel topique radio protectif pour muqueuses
PCT/SE1987/000359 WO1988001163A1 (fr) 1986-08-18 1987-08-14 Gel radioprotecteur topique pour les muqueuses
FI890715A FI890715A7 (fi) 1986-08-18 1987-08-14 Paikallinen, säteilyltä suojaava geeli limakalvoja varten
DE8787850244T DE3770753D1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
AT87850244T ATE64308T1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
IL83566A IL83566A (en) 1986-08-18 1987-08-17 Radioprotective gel containing vasoconstrictors for topical application on mucosa
NO881580A NO881580L (no) 1986-08-18 1988-04-12 Lokal straalingsbeskyttende gel for slimhinne.
DK206688A DK206688A (da) 1986-08-18 1988-04-15 Topisk straalebeskyttende gel for mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Publications (3)

Publication Number Publication Date
SE8603481D0 SE8603481D0 (sv) 1986-08-18
SE8603481L SE8603481L (sv) 1988-02-19
SE457055B true SE457055B (sv) 1988-11-28

Family

ID=20365336

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Country Status (11)

Country Link
EP (1) EP0265400B1 (fr)
JP (1) JPH02500668A (fr)
AT (1) ATE64308T1 (fr)
AU (1) AU609417B2 (fr)
DE (1) DE3770753D1 (fr)
DK (1) DK206688A (fr)
FI (1) FI890715A7 (fr)
IL (1) IL83566A (fr)
NO (1) NO881580L (fr)
SE (1) SE457055B (fr)
WO (1) WO1988001163A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300036A4 (fr) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd Compositions pharmaceutiques a base de vasopressine.
DE3856315T2 (de) * 1987-10-22 1999-10-14 The Procter & Gamble Co. Chelatbildner enthaltende Lichtschutzmittel
EP1061937A1 (fr) * 1998-03-10 2000-12-27 University Of Southern California Methodes ameliorees de radiotherapie
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
KR100844285B1 (ko) * 2000-10-27 2008-07-09 레오 파마 에이/에스 하나 이상의 비타민 d 또는 비타민 d 동족체 및 하나이상의 코르티코스테로이드를 함유하는 국부용 조성물
CA2501981A1 (fr) * 2002-10-01 2004-04-15 Mitos Pharmaceuticals, Inc. Preparations de radioprotection a l'oxyde d'azote et leurs methodes d'utilisation
US7183255B2 (en) * 2003-02-26 2007-02-27 Intradialytic Pharmaceuticals Method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
PL1890732T3 (pl) 2005-06-17 2018-11-30 Wisconsin Alumni Research Foundation Preparaty zwężające naczynia krwionośne do podawania miejscowego i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
KR101194586B1 (ko) 2006-02-10 2012-10-25 훼링 비.브이. 신규 화합물
WO2009037586A2 (fr) 2007-08-14 2009-03-26 Ferring B.V. Utilisation d'agonistes peptidiques du récepteur de la vasopressine
JP2015533161A (ja) * 2012-10-16 2015-11-19 ローム アンド ハース カンパニーRohm And Haas Company エモリエント含有水性ゲル

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785103A (en) * 1953-12-31 1957-03-12 Abbott Lab L-desoxyephedrine inhalant preparation
CH455823A (de) * 1964-08-01 1968-05-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von Peptiden
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
DE3106619A1 (de) * 1981-02-23 1982-09-09 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitung in form eines mikroklysmas

Also Published As

Publication number Publication date
EP0265400B1 (fr) 1991-06-12
DE3770753D1 (de) 1991-07-18
SE8603481L (sv) 1988-02-19
AU609417B2 (en) 1991-05-02
AU7852887A (en) 1988-03-08
EP0265400A2 (fr) 1988-04-27
IL83566A0 (en) 1988-01-31
IL83566A (en) 1991-06-10
FI890715L (fi) 1989-02-15
DK206688D0 (da) 1988-04-15
NO881580D0 (no) 1988-04-12
FI890715A0 (fi) 1989-02-15
EP0265400A3 (en) 1988-11-09
DK206688A (da) 1988-06-13
ATE64308T1 (de) 1991-06-15
SE8603481D0 (sv) 1986-08-18
WO1988001163A1 (fr) 1988-02-25
NO881580L (no) 1988-05-30
FI890715A7 (fi) 1989-02-15
JPH02500668A (ja) 1990-03-08

Similar Documents

Publication Publication Date Title
SE457055B (sv) Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
Fassoulaki et al. Intransal adminstration of nitroglycerine attenuates the pressor responsive to laryngoscopy and intubation of the trachea
Stoney et al. The incidence of venous thrombosis following long-term transvenous pacing
Grondin et al. Influence of a critical coronary artery stenosis on myocardial protection through cold potassium cardioplegia
Zalewski et al. Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with intermittent occlusion.
UA77640C2 (uk) Водна фармацевтична композиція для нанесення на слизову оболонку носа
Kerr et al. Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug
Su et al. Nasal drug delivery system of a quaternary ammonium compound: clofilium tosylate
Hilton et al. Perfusion of the isolated adrenals in situ
US4832954A (en) Nicorandil containing external preparations
Altura Evidence that endogenous vasopressin plays a protective role in circulatory shock. Role for reticuloendothelial system using Brattleboro rats
CA1249223A (fr) Formulations de medicaments solides et suspensions stables
Fagbemi et al. Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia
GB2203044A (en) Nasal compositions
Fawaz Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation
Bixler et al. Effects of procaine-induced cardioplegia on myocardial ischemia, myocardial edema, and postarrest ventricular function: a comparison with potassium-induced cardioplegia and hypothermia
Aggarwal et al. Phrenic nerve palsy: a rare complication of indwelling subclavian vein catheter
Jastremski et al. Femoral venous catheterization during cardiopulmonary resuscitation: a critical appraisal
Lu et al. Antiarrhythmic effects of nebivolol in experimental models in vivo
Curtis et al. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats
Hatori et al. Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion
WILSON et al. In extremis use of a Foley catheter in a cardiac stab wound
Goerg et al. Azodisalicylate (Azodisal Sodium) Causes Intestinal Secretion: Comparative Study of the Effect of Azodisalicylate, Sulfasalazine, 5-Aminosalicylic Acid and Sulfapyridine on the Water and Electrolyte Transfer and the Morphology of the Rat Ileum and Colon in vivo
Ebert et al. Effect of neurogenic reflexes on heart rate during systemic hypotension
EP3946379A1 (fr) Agents polymères pour réanimation cardiopulmonaire

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8603481-6

Effective date: 19920306

Format of ref document f/p: F